Spruce Street Capital LP: 13F holdings
CIK 20501942026Q2
| Positions | 30 |
|---|
| Reported value | $509.7m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 30 (+2 vs prior quarter) |
|---|
| Reported value | $509.7m (+22.5%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| KINIKSA PHARMACEUTICALS INTL | 918,070 | $58.7m | 11.5% |
| RLAY RELAY THERAPEUTICS INC | 2,984,125 | $55.8m | 11.0% |
| LBRX LB PHARMACEUTICALS INC | 1,376,159 | $44.7m | 8.8% |
| RLMD RELMADA THERAPEUTICS INC | 6,391,328 | $44.2m | 8.7% |
| ANRO ALTO NEUROSCIENCE INC | 1,353,047 | $35.7m | 7.0% |
| DNTH DIANTHUS THERAPEUTICS INC | 354,816 | $34.6m | 6.8% |
| ALKERMES PLC | 543,876 | $28.5m | 5.6% |
| SVRA SAVARA INC | 3,452,576 | $21.3m | 4.2% |
| PCVX VAXCYTE INC | 306,047 | $17.8m | 3.5% |
| ELVN ENLIVEN THERAPEUTICS INC | 329,006 | $16.7m | 3.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2050194")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples